Tom Flottman’s firm, Flottman Co., produces pharmaceutical inserts and faces potential job losses due to a proposed bill favoring electronic over paper materials. Flottman argues that paper inserts are essential for patient safety and disaster scenarios. Losing this business line could result in significant staff reductions and impact specialized production techniques.
Read the whole here.
